NWM
RVPH

NRI Wealth Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

NRI Wealth Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.17K Sell
569
-50
-8% -$556 ﹤0.01% 31
2025
Q3 		$4.56K Hold
619
– – ﹤0.01% 32
2025
Q2 		$4.72K Hold
619
– – ﹤0.01% 30
2025
Q1 		$11.8K Hold
619
– – 0.01% 25
2024
Q4 		$22.4K Buy
+619
New +$17.2K 0.02% 26
2024
Q2 		$15.8K Hold
619
– – 0.01% 27
2024
Q1 		$46.8K Hold
619
– – 0.04% 28
2023
Q4 		$63.8K Buy
+619
New +$55.5K 0.06% 28

Other funds holding RVPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NRI Wealth Management's RVPH Position: Q4 2025 in Review

NRI Wealth Management reduced its REVIVA PHARMA HLDGS INC (RVPH) stake by 8.1% in Q4 2025, selling an estimated $556 and leaving 569 shares worth $3.17K. The position accounts for ﹤0.01% of the portfolio, ranked #31.

NRI Wealth Management first reported a position in RVPH in Q4 2023 and has held it in 8 quarters since. The position peaked at $63.8K in Q4 2023. 48 funds tracked by Wall St. Rank hold RVPH as of Q4 2025.

  • NRI Wealth Management held 569 shares of REVIVA PHARMA HLDGS INC worth $3.17K as of Q4 2025.
  • NRI Wealth Management sold 50 REVIVA PHARMA HLDGS INC shares in Q4 2025, an estimated $556.
  • REVIVA PHARMA HLDGS INC made up ﹤0.01% of NRI Wealth Management's portfolio in Q4 2025, its #31 holding.
  • NRI Wealth Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2023 and has held it in 8 quarters since.
  • NRI Wealth Management's REVIVA PHARMA HLDGS INC position peaked at $63.8K in Q4 2023.
  • 48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2025.

Based on NRI Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.